Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Hedge Fund and Insider Trading News: Daniel Loeb, Alan Howard, ADMA Biologics Inc (ADMA), Altair Engineering Inc (ALTR), QTS Realty Trust Inc (QTS), and More

US Fundraising for Special Purpose Acquisition Vehicles Hits Record this Year (AFR.com)
Special purpose acquisition vehicles (spacs) are hitting the US market at the fastest rate on record, attracting the likes of Goldman Sachs and hedge fund investor Daniel Loeb for the two largest such deals in 2018. Spacs have raised $US4.5bn so far in 2018, the largest amount for this type of fundraising in the period, according to Dealogic, which began recording the deals in 1995. That followed a brisk 2017, the second strongest year on record with nearly $US10bn sold. Spacs function as a type of publicly-traded buyout fund with investors buying spacs giving their sponsors a “blank cheque” for an acquisition within two years.

DGAP-News: FinLab AG: Hedge Fund Manager Alan Howard, Axel Springer and Existing Investors Invest EUR 6m in FinLab’s Portfolio Company Nextmarkets; Nextmarkets Today is Celebrating its ‘Go-Live’ (Business Insider)
FinLab AG: Hedge fund manager Alan Howard, Axel Springer and existing investors invest EUR 6m in FinLab’s portfolio company nextmarkets; Nextmarkets today is celebrating its ‘go-live’ The issuer is solely responsible for the content of this announcement.

Brad Pitt’s “Professional Friendship” Partner Neri Oxman Spotted in Paris with Her Rumored Billionaire Boyfriend (Vanity Fair)
You may recognize Oxman from headlines such as “Brad Pitt spending time with rockstar MIT professor” and “Brad Pitt and Neri Oxman: Inside Their Romance” and, a favorite, “Brad Pitt and MIT genius Neri Oxman pose together in previously-unseen snap as SIX MONTH relationship is revealed” in April. Together, the headlines coagulated into something like truth, though neither party ever acknowledged the rumors or commented. One anonymous source maintained it was a “professional relationship.” Professional relationship or not, now she’s back to being “openly affectionate” with Ackman, and inspiring anonymous sources to say things like, “Bill won his match, and has won the girl. Brad Pitt will need to up his tennis game-and his educational degrees-if he wants such a super impressive, and highly intellectual woman.”

Egerton Partner Exits After 12 Years (HFM)
Egerton Capital partner and analyst Nicholas Jones has retired from the firm, HFMWeek understands. Jones worked at the London-headquartered hedge fund for around 12 years and since 2013 held a CF4 partner role at the firm, regulatory filings indicate. Prior to joining Egerton in 2005, he worked as an analyst.

Insider Buying: ADMA Biologics Inc (ADMA) CEO Buys $249,998.78 in Stock (WeekHerald.com)
ADMA Biologics Inc (NASDAQ:ADMA) CEO Adam S. Grossman bought 52,301 shares of the business’s stock in a transaction that occurred on Friday, June 8th. The shares were acquired at an average price of $4.78 per share, for a total transaction of $249,998.78. Following the transaction, the chief executive officer now owns 32,527 shares in the company, valued at $155,479.06. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website.

Insider Selling: Altair Engineering Inc (ALTR) Director Sells $4,011,600.00 in Stock (StockNewsTimes.com)
Altair Engineering Inc (NASDAQ:ALTR) Director James E. Brancheau sold 120,000 shares of the firm’s stock in a transaction on Monday, June 11th. The stock was sold at an average price of $33.43, for a total value of $4,011,600.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission.

Insider Buying: QTS Realty Trust Inc Class A (QTS) CEO Purchases 30,000 Shares of Stock (RegistrarJournal.com)
QTS Realty Trust Inc (NYSE:QTS) CEO Chad L. Williams acquired 30,000 shares of the company’s stock in a transaction on Thursday, May 31st. The stock was acquired at an average cost of $37.68 per share, with a total value of $1,130,400.00. Following the completion of the purchase, the chief executive officer now directly owns 338,528 shares in the company, valued at $12,755,735.04. The purchase was disclosed in a filing with the SEC.

Insider Selling: PAVmed Inc (PAVM) Major Shareholder Sells $19,032.00 in Stock (StockNewsTimes.com)
PAVmed Inc (NASDAQ:PAVM) major shareholder Ira Scott Greenspan sold 18,300 shares of the stock in a transaction that occurred on Friday, June 8th. The stock was sold at an average price of $1.04, for a total value of $19,032.00. The sale was disclosed in a filing with the Securities & Exchange Commission.

Insider Buying: Sears Hometown and Outlet Stores Inc (SHOS) CEO Purchases $23,023.00 in Stock (LedgerGazette.com)
Sears Hometown and Outlet Stores Inc (NASDAQ:SHOS) CEO William A. Powell acquired 10,010 shares of the firm’s stock in a transaction on Monday, June 11th. The stock was purchased at an average cost of $2.30 per share, with a total value of $23,023.00. The transaction was disclosed in a legal filing with the SEC.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.